Medtronic's Evera ICD portfolio scores CE Mark

Editorial Staff | | Cardiovascular Business | Heart Rhythm

Medtronic has received CE Mark for the Evera portfolio of implantable cardioverter-defibrillators (ICDs).

With increased longevity and SmartShock shock reduction technology, Minneapolis-based Medtronic said the new family of ICDs is the first to feature the PhysioCurve design, a contoured shape. In addition, Evera also is paired with the Sprint Quattro Secure lead. Also included in the new ICD portfolio is OptiVol 2.0 fluid status monitoring and complete diagnostics.

The Medtronic Evera ICD is not approved in the U.S.

Editorial Staff

Related Content

Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup